StoxRadar is free — only 218 spots left in beta.

SPY$777.22-0.24%QQQ$757.73-0.25%DIA$511.02-0.69%IWM$277.70-1.29%AAPL$336.67+0.91%MSFT$529.76+0.09%NVDA$237.47-0.74%AMZN$259.92+1.42%GOOGL$350.50+0.81%META$721.31-2.38%TSLA$377.81-0.75%JPM$329.58-0.51%GLD$375.88-1.67%BTC$36.88-2.54%IBIT$47.21-2.64%SPY$777.22-0.24%QQQ$757.73-0.25%DIA$511.02-0.69%IWM$277.70-1.29%AAPL$336.67+0.91%MSFT$529.76+0.09%NVDA$237.47-0.74%AMZN$259.92+1.42%GOOGL$350.50+0.81%META$721.31-2.38%TSLA$377.81-0.75%JPM$329.58-0.51%GLD$375.88-1.67%BTC$36.88-2.54%IBIT$47.21-2.64%

StoxRadar is free.

SXTC

SXTC

NASDAQ

China SXT Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$2.83
+1.58+126.40%
Day Range: $1.87 – $9.59
Market Cap
$1.51M
Volume
144.84M
52W High
$83760.00
52W Low
$1.18
P/E Ratio
-0.36
EPS (TTM)
$-10.45
Div Yield
—
Beta
1.86

Price History

08-2609-0309-1409-2209-30$1.2$1.8$2.4$3$3.6

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

CEO
Feng Zhou
Employees
56
Headquarters
Taizhou, CN
IPO Date
2019-01-04
BETA

Get started for full access.